<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18207">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01766310</url>
  </required_header>
  <id_info>
    <org_study_id>Folic-01</org_study_id>
    <nct_id>NCT01766310</nct_id>
  </id_info>
  <brief_title>Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children</brief_title>
  <official_title>Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children: a Randomized Double Blinded Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Sirikit National Institute of Child Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen Sirikit National Institute of Child Health</source>
  <oversight_info>
    <authority>Thailand: Ministry of Public Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study was to determine whether folic acid supplementation could
      reduce plasma homocysteine in obese children and to determine the association between
      dietary folate, serum folate and homocysteine level through the randomized double blinded
      placebo controlled trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atherosclerosis is common &amp; remains a significant clinical problem because of leading to
      myocardial infarction, stroke and cardiovascular death.  Many studies founded
      hyperhomocysteinemia is an independent risk factor for those cardiovascular diseases which
      take responsible for about 10% of total cardiovascular disease risk. Reduction of elevated
      plasma homocysteine may prevent up to 25% of cardiovascular events. One of modifiable cause
      of hyperhomocysteinemia is prevention of vitamin deficiency, especially folate deficiency.

      Obese Thai children are probable risk for folate deficiency due to low dietary folate intake
      and low serum folate level from unbalanced diet (low vegetables intake &amp; high fat diet) and
      high prevalence of thalassemia. Moreover obese children are also at risk of atherosclerosis.
      However, no data have been reported about effect of folic acid supplementation on
      homocysteine level in these patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>homocysteine level</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mean difference of homocysteine level between 2 treatment groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dietary folate level</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>correlation between dietary folate and  plasma homocysteine level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum folate level</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>correlation between  serum folate and plasma homocysteine level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum vitamin B12 level</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>correlation between serum vitamin B12 and plasma homocysteine level</description>
  </secondary_outcome>
  <other_outcome>
    <measure>prevalence of hyperhomocysteinemia</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>prevalence of hyperhomocysteinemia</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hyperhomocysteinemia</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo tablet in the same appearance and taste with folic acid orally once a day for 8 weeks of the study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>folic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Folic acid tablet 5mg per day orally (5mg/tablet) once a day for 8 weeks of the study</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Folic Acid</intervention_name>
    <arm_group_label>folic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>sugar tablet manufactured to mimic folic acid tablet</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age between 9-18 years

          -  Diagnosed obesity (BMI more than median plus two of standard deviation for age and
             sex according to WHO reference 2007)

        Exclusion Criteria:

          -  Secondary obesity

          -  Thalassemia disease

          -  Renal and hepatic dysfunction

          -  Drugs: anticonvulsant, estrogen, thiazides, metformin, cholestyramine, methotrexate,
             fibrates, nicotinic acid

          -  Previous  vitamin supplementation 1 month before study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orawan Iamopas, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Sirikit National Institute of Child Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Pediatrics, Queen Sirikit National Institute of Child Health</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Sirikit National Institute of Child Health</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond). 2006 Aug;30(8):1197-202. Epub 2006 Feb 21.</citation>
    <PMID>16491109</PMID>
  </reference>
  <reference>
    <citation>Papandreou D, Malindretos P, Arvanitidou M, Makedou A, Rousso I. Oral supplementation of folic acid for two months reduces total serum homocysteine levels in hyperhomocysteinemic Greek children. Hippokratia. 2010 Apr;14(2):105-8.</citation>
    <PMID>20596265</PMID>
  </reference>
  <reference>
    <citation>Papandreou D, Malindretos P, Arvanitidou M, Makedou A, Rousso I. Homocysteine lowering with folic acid supplements in children: effects on blood pressure. Int J Food Sci Nutr. 2010 Feb;61(1):11-7. doi: 10.3109/09637480903286371.</citation>
    <PMID>19939196</PMID>
  </reference>
  <reference>
    <citation>Pe√±a AS, Wiltshire E, Gent R, Hirte C, Couper J. Folic acid improves endothelial function in children and adolescents with type 1 diabetes. J Pediatr. 2004 Apr;144(4):500-4.</citation>
    <PMID>15069400</PMID>
  </reference>
  <reference>
    <citation>Gargari BP, Aghamohammadi V, Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract. 2011 Oct;94(1):33-8. doi: 10.1016/j.diabres.2011.07.003. Epub 2011 Jul 28.</citation>
    <PMID>21802161</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 6, 2013</lastchanged_date>
  <firstreceived_date>January 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen Sirikit National Institute of Child Health</investigator_affiliation>
    <investigator_full_name>Orawan Iamopas</investigator_full_name>
    <investigator_title>Queen Sirikit National Institute of Child Health</investigator_title>
  </responsible_party>
  <keyword>Folic acid</keyword>
  <keyword>Folate</keyword>
  <keyword>Homocysteine</keyword>
  <keyword>Obese</keyword>
  <keyword>Children</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Hyperhomocysteinemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Hematinics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
